Cooper Companies | COO - Costo Del Venduto

Prezzo Delle Azioni
61.34
Cambio Giornaliero
-1.75 -2.77%
Mensile
-11.50%
Annuale
-24.89%
Q2 Previsione
63.04




Costo Del Venduto Cambiamento Data
Abbott USD 5.3B 380M 2026-03
Align Technology USD 363.97M 7.48M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Bausch Health Companies USD 1.03B 284M 2025-12
Baxter International USD 2.4B 512M 2025-12
Bayer EUR 4.5B 194M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.83B 8M 2026-03
Cooper Companies USD 376.8M 87.4M 2025-12
Dentsply International USD 518M 55M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 940.3M 21.6M 2026-03
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Novartis USD 3.54B 7M 2025-12
ResMed USD 555.85M 29.13M 2025-12
STAAR Surgical USD 14.06M 2.8M 2025-12
Steris USD 840.7M 26.3M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Utah Medical Products USD 3.78M 419K 2025-12
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03